Home HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system
Article
Licensed
Unlicensed Requires Authentication

HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system

  • Patricia Kaiser EMAIL logo , Michael Spannagl , Christel van Campenhout , Yolande Lenga , Carla Siebelder and Cas Weykamp
Published/Copyright: May 12, 2016
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 54 Issue 11

Abstract

Background:

External quality assessment/proficiency test (EQA/PT) organizers play an important role in monitoring the performance of HbA1c measurements. With increasing quality of the assays, HbA1c is increasingly used for diagnosis of diabetes and the demands on EQA/PT organizers themselves are rising constantly. EQA organizers in Germany (INSTAND), Belgium (WIV/IPV), and the Netherlands (SKML) organized a program with commutable samples and target values assigned with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference system. The aim of this project was to confirm the logistic feasibility of organizing synchronically in the three countries, an accuracy-based EQA program with fresh whole blood, to investigate the performance of HbA1c assays within and across countries and manufacturers, and to review the EQA acceptance limits.

Methods:

Throughout 2015, ten fresh whole blood samples were supplied to the participants. Aggregated results were evaluated according to the IFCC model for quality targets at four levels: overall, per country, per manufacturer, and per country per manufacturer.

Results:

Robust results in summer and winter demonstrated the feasibility of organizing an EQA with fresh whole blood samples in three countries. The overall performances, as well as the performance for each country were very similar: results fell within the IFCC criteria. Although substantial differences between results from different manufacturers were present, the performances of laboratories using tests of the same manufacturer were strikingly similar in the three countries, suggesting that the quality of HbA1c assays is for the most part manufacturer- related. The improved design of the EQA program also suggested that acceptance limits for performance can be reduced to approximately 8%.

Keywords: EQA/PT; fresh whole blood; HbA1c; IFCC reference system
Corresponding author: Dr. Patricia Kaiser, INSTAND e.V., Reference Laboratory, Düsseldorf, Germany, Fax: +49 211 15921356

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. American Diabetes Association. Standards of medical care in diabetes. 2011. Diabetes Care 2011;34(Suppl 1):S11–61.10.2337/dc11-S011Search in Google Scholar PubMed PubMed Central

2. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1–47.10.1373/clinchem.2010.161596Search in Google Scholar PubMed

3. Nathan D. On behalf of the Expert Committee. International Expert Committee on the role of A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.10.2337/dc09-1777Search in Google Scholar

4. Mosca A, Paleari R, Carobene A, Weykamp C, Ceriotti F. Performance of glycated hemoglobin (HbA1c) methods evaluated with EQAS studies using fresh blood samples: still space for improvements. Clin Chim Acta 2015;451:305–9.10.1016/j.cca.2015.10.014Search in Google Scholar PubMed

5. EN ISO/IEC 17043, Conformity assessment –General requirements for proficiency testing. International Organization for Standardization (Geneva, Switzerland).Search in Google Scholar

6. ISO 13528, Statistical methods for use in proficiency testing by interlaboratory comparisons. International Organization for Standardization (Geneva, Switzerland).Search in Google Scholar

7. Jeppson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for measurement of HbA1c in human blood. Clin Chem Lab Med 2002;40:78–89.10.1515/CCLM.2002.016Search in Google Scholar PubMed

8. Kaiser P, Akerboom T, Molnar P, Reinauer H. Modified HPLC-electrospray ionization/mass spectrometry method for HbA1c based on IFCC reference measurement procedure. Clin Chem 2008;54:1018–22.10.1373/clinchem.2007.100875Search in Google Scholar PubMed

9. Evaluation of measurement data – Guide to the expression of uncertainty in measurement. BIPM Joint Comm Guides Metrol 100:2008.Search in Google Scholar

10. Weykamp C, John G, Gillery P, English E, Li Linong, Lenters-Westra E, et al. Investigation of 2 models to set and evaluate quality targets for HbA1c: biological variation and sigma-metrics. Clin Chem 2015;61:752–9.10.1373/clinchem.2014.235333Search in Google Scholar PubMed PubMed Central

11. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriums-medizinischer Untersuchungen. Dtsch Arztebl 2014;38:A1583–618.10.1515/labmed-2013-0040Search in Google Scholar

12. Mosca A, Weykamp C. Feasibility of an EQAS for HbA1c in Italy using fresh blood samples. Clin Chem Lab Med 2014;52:e151–3.10.1515/cclm-2014-0084Search in Google Scholar PubMed

13. Weykamp C, Mosca A, Gillery P, Panteghini M. The analytical goals for hemoglobin A(1c) measurement in IFCC units and national Glycohemoglobin Standardization Program Units are different. Clin Chem 2011;57:1204–6.10.1373/clinchem.2011.162719Search in Google Scholar PubMed

14. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1677–80.10.1373/clinchem.2011.168641Search in Google Scholar PubMed

Supplemental Material:

The online version of this article (DOI: 10.1515/cclm-2016-0123) offers supplementary material, available to authorized users.

Received: 2016-2-16
Accepted: 2016-4-7
Published Online: 2016-5-12
Published in Print: 2016-11-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. CCLM Award for the Most Cited Paper Recently Published
  4. Laboratory economics. Risk or opportunity?
  5. Reviews
  6. Molecular diagnosis and precision medicine in allergy management
  7. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
  8. Opinion Paper
  9. Role of microsatellite instability, immunohistochemistry and mismatch repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre syndrome
  10. Genetics and Molecular Diagnostics
  11. Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas
  12. False low holotranscobalamin levels in a patient with a novel TCN2 mutation
  13. General Clinical Chemistry and Laboratory Medicine
  14. Quality performance of laboratory testing in pharmacies: a collaborative evaluation
  15. Cost evaluation of clinical laboratory in Taiwan’s National Health System by using activity-based costing
  16. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters
  17. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system
  18. Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate
  19. Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them
  20. Reference Values and Biological Variations
  21. Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood
  22. Hematology and Coagulation
  23. Evaluation of Mindray BC-6800 body fluid mode for automated cerebrospinal fluid cell counting
  24. Cancer Diagnostics
  25. Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix
  26. Cardiovascular Diseases
  27. High incidence of macrotroponin I with a high-sensitivity troponin I assay
  28. Infectious Diseases
  29. Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia
  30. Letter to the Editor
  31. The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey
  32. Quality of reporting of diagnostic test accuracy studies in medical laboratory journals
  33. Impact of under-filled blood collection tubes containing K2EDTA and K3EDTA as anticoagulants on automated complete blood count (CBC) testing
  34. Stability of plasma albumin depends on measurement method
  35. Evaluation of screening method for Bence Jones protein analysis
  36. Reference intervals for the Kryptor second-generation chromogranin A assay
  37. Evaluation of an automated urinary iodine measurement using AU5800 analyzer with AutoLab Iodine reagent
  38. Evaluation of the accuracy of complete blood count for insufficient blood samples
  39. The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example
  40. Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomalies
  41. Standardized fixation process is crucial to permit molecular analyses in formalin-fixed and paraffin-embedded melanoma samples
  42. Congress Abstracts
  43. 48th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  44. 8th Santorini Conference Systems Medicine and Personalised Health and Therapy
  45. Congress of Laboratory Medicine and Clinical Chemistry
https://doi.org/10.1515/cclm-2016-0123
Keywords for this article
EQA/PT; fresh whole blood; HbA1c; IFCC reference system

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. CCLM Award for the Most Cited Paper Recently Published
  4. Laboratory economics. Risk or opportunity?
  5. Reviews
  6. Molecular diagnosis and precision medicine in allergy management
  7. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
  8. Opinion Paper
  9. Role of microsatellite instability, immunohistochemistry and mismatch repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre syndrome
  10. Genetics and Molecular Diagnostics
  11. Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas
  12. False low holotranscobalamin levels in a patient with a novel TCN2 mutation
  13. General Clinical Chemistry and Laboratory Medicine
  14. Quality performance of laboratory testing in pharmacies: a collaborative evaluation
  15. Cost evaluation of clinical laboratory in Taiwan’s National Health System by using activity-based costing
  16. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters
  17. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system
  18. Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate
  19. Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them
  20. Reference Values and Biological Variations
  21. Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood
  22. Hematology and Coagulation
  23. Evaluation of Mindray BC-6800 body fluid mode for automated cerebrospinal fluid cell counting
  24. Cancer Diagnostics
  25. Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix
  26. Cardiovascular Diseases
  27. High incidence of macrotroponin I with a high-sensitivity troponin I assay
  28. Infectious Diseases
  29. Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia
  30. Letter to the Editor
  31. The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey
  32. Quality of reporting of diagnostic test accuracy studies in medical laboratory journals
  33. Impact of under-filled blood collection tubes containing K2EDTA and K3EDTA as anticoagulants on automated complete blood count (CBC) testing
  34. Stability of plasma albumin depends on measurement method
  35. Evaluation of screening method for Bence Jones protein analysis
  36. Reference intervals for the Kryptor second-generation chromogranin A assay
  37. Evaluation of an automated urinary iodine measurement using AU5800 analyzer with AutoLab Iodine reagent
  38. Evaluation of the accuracy of complete blood count for insufficient blood samples
  39. The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example
  40. Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomalies
  41. Standardized fixation process is crucial to permit molecular analyses in formalin-fixed and paraffin-embedded melanoma samples
  42. Congress Abstracts
  43. 48th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  44. 8th Santorini Conference Systems Medicine and Personalised Health and Therapy
  45. Congress of Laboratory Medicine and Clinical Chemistry
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 29.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0123/html
Scroll to top button